OneAscent Financial Services LLC Has $1.63 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

OneAscent Financial Services LLC boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 2.5% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,288 shares of the healthcare conglomerate’s stock after buying an additional 80 shares during the quarter. OneAscent Financial Services LLC’s holdings in UnitedHealth Group were worth $1,627,000 as of its most recent filing with the SEC.

A number of other large investors have also recently bought and sold shares of UNH. Paralel Advisors LLC boosted its holdings in shares of UnitedHealth Group by 1.1% in the 3rd quarter. Paralel Advisors LLC now owns 4,047 shares of the healthcare conglomerate’s stock valued at $2,040,000 after buying an additional 44 shares during the last quarter. Bamco Inc. NY raised its holdings in shares of UnitedHealth Group by 4.5% in the 3rd quarter. Bamco Inc. NY now owns 46,042 shares of the healthcare conglomerate’s stock valued at $23,214,000 after purchasing an additional 1,986 shares during the period. Staley Capital Advisers Inc. grew its holdings in UnitedHealth Group by 6.9% during the third quarter. Staley Capital Advisers Inc. now owns 1,073 shares of the healthcare conglomerate’s stock worth $541,000 after purchasing an additional 69 shares during the period. Van Lanschot Kempen Investment Management N.V. raised its stake in UnitedHealth Group by 53.4% in the third quarter. Van Lanschot Kempen Investment Management N.V. now owns 34,753 shares of the healthcare conglomerate’s stock valued at $17,522,000 after buying an additional 12,103 shares during the period. Finally, Ancora Advisors LLC boosted its stake in shares of UnitedHealth Group by 0.6% during the 3rd quarter. Ancora Advisors LLC now owns 108,412 shares of the healthcare conglomerate’s stock worth $54,660,000 after acquiring an additional 619 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

NYSE UNH traded up $22.82 during trading on Friday, hitting $509.26. 22,734,197 shares of the company’s stock were exchanged, compared to its average volume of 3,685,941. The stock’s 50 day moving average price is $498.34 and its two-hundred day moving average price is $502.27. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $554.70. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.69. The company has a market cap of $468.72 billion, a PE ratio of 31.15, a P/E/G ratio of 1.41 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The firm had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. During the same quarter last year, the business posted $6.26 earnings per share. The company’s quarterly revenue was up 8.6% on a year-over-year basis. Research analysts expect that UnitedHealth Group Incorporated will post 27.57 EPS for the current year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Stockholders of record on Monday, June 17th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, June 17th. This represents a $8.40 annualized dividend and a dividend yield of 1.65%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s dividend payout ratio is currently 51.34%.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on UNH shares. Piper Sandler lifted their price objective on shares of UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 17th. TD Cowen lowered their price target on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a report on Wednesday, April 10th. Truist Financial reaffirmed a “buy” rating and issued a $600.00 target price on shares of UnitedHealth Group in a research report on Wednesday, April 17th. Bank of America restated a “buy” rating and issued a $675.00 price target on shares of UnitedHealth Group in a research note on Thursday, March 7th. Finally, Erste Group Bank reissued a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Three investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $579.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.